Drug class in one race
CD33 drugs for Acute Myeloid Leukemia
5 tracked CD33 drugs in the Acute Myeloid Leukemia race. The class explanation lives on the CD33 page; the full indication pipeline across every mechanism is on the Acute Myeloid Leukemia page.
1 approved / phase 41 Phase 31 Phase 2/31 Phase 1/21 Phase 1
Head-to-head evidence: Anti-CD33 CAR T-cells vs BL-M11D1 · Anti-CD33 CAR T-cells vs Gemtuzumab Ozogamicin · Anti-CD33 CAR T-cells vs Lintuzumab-Ac225 · Anti-CD33 CAR T-cells vs PRGN-3006 T Cells · BL-M11D1 vs Gemtuzumab Ozogamicin · BL-M11D1 vs Lintuzumab-Ac225